UBS Group
CLMT icon

UBS Group’s Calumet Specialty Products CLMT Stock Holding History

UBS Group’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-200
Closed -$5K – 8518
2015
Q1 		$5K Buy
+200
New +$5.06K ﹤0.01% 8086

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group's CLMT Position: Q1 2026 in Review

UBS Group reduced its Calumet Specialty Products (CLMT) stake by 43% in Q1 2026, selling an estimated $3.98M and leaving 204,725 shares worth $7.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3661.

UBS Group first reported a position in CLMT in Q4 2014 and has held it in 46 quarters since. The position peaked at $19.4M in Q2 2015. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • UBS Group held 204,725 shares of Calumet Specialty Products worth $7.35M as of Q1 2026.
  • UBS Group sold 153,903 Calumet Specialty Products shares in Q1 2026, an estimated $3.98M.
  • Calumet Specialty Products made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3661 holding.
  • UBS Group first reported a position in Calumet Specialty Products in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Calumet Specialty Products position peaked at $19.4M in Q2 2015.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.